Development
Thermo Fisher Scientific Inc.
TMO
$415.15
$0.610.15%
NYSE
| 12/31/2023 | 09/30/2023 | 07/01/2023 | 04/01/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.08B | 6.15B | 3.13B | 3.48B | 8.52B |
| Total Receivables | 9.66B | 9.84B | 9.49B | 9.30B | 9.43B |
| Inventory | 5.09B | 5.40B | 5.66B | 5.66B | 5.63B |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.76B | 1.70B | 1.72B | 1.77B | 1.64B |
| Total Current Assets | 24.59B | 23.09B | 20.00B | 20.21B | 25.23B |
|
|
|||||
| Total Current Assets | 24.59B | 23.09B | 20.00B | 20.21B | 25.23B |
| Net Property, Plant & Equipment | 11.00B | 9.17B | 9.29B | 9.35B | 10.87B |
| Long-term Investments | 44.02B | 43.58B | 43.27B | 43.14B | 41.20B |
| Goodwill | 44.02B | 43.58B | 43.27B | 43.14B | 41.20B |
| Total Other Intangibles | 16.71B | 17.09B | 17.44B | 17.97B | 17.48B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.36B | 4.04B | 4.10B | 3.93B | 2.22B |
| Total Assets | 98.73B | 97.06B | 94.11B | 94.66B | 97.15B |
|
|
|||||
| Total Accounts Payable | 2.87B | 2.51B | 2.42B | 2.80B | 3.38B |
| Total Accrued Expenses | 4.52B | 4.23B | 4.19B | 4.25B | 5.12B |
| Short-term Debt | -- | -- | 500.00M | 824.00M | 310.00M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.87B | 4.80B | 4.31B | 5.30B | 5.54B |
| Total Finance Division Other Current Liabilities | 2.75B | 2.62B | 2.69B | 2.72B | 2.66B |
| Total Other Current Liabilities | 2.75B | 2.62B | 2.69B | 2.72B | 2.66B |
| Total Current Liabilities | 14.01B | 14.16B | 14.11B | 15.88B | 17.01B |
|
|
|||||
| Total Current Liabilities | 14.01B | 14.16B | 14.11B | 15.88B | 17.01B |
| Long-Term Debt | 31.41B | 30.44B | 29.01B | 29.01B | 28.78B |
| Short-term Debt | -- | -- | 500.00M | 824.00M | 310.00M |
| Capital Leases | 1.43B | 200.00M | 202.00M | 206.00M | 1.52B |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 5.03B | 6.79B | 6.87B | 7.13B | 5.69B |
| Total Liabilities | 51.88B | 51.59B | 50.19B | 52.23B | 53.01B |
|
|
|||||
| Common Stock & APIC | 17.73B | 17.61B | 17.47B | 17.33B | 17.18B |
| Retained Earnings | 47.36B | 45.87B | 44.29B | 43.06B | 41.91B |
| Treasury Stock & Other | -18.36B | -18.15B | -18.01B | -18.14B | -15.12B |
| Total Common Equity | 46.74B | 45.33B | 43.75B | 42.26B | 43.98B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 46.74B | 45.33B | 43.75B | 42.26B | 43.98B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 107.00M | 136.00M | 163.00M | 176.00M | 170.00M |
| Total Equity | 46.84B | 45.46B | 43.92B | 42.43B | 44.15B |
|
|
|||||